Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model.

Liu C, Zhao Y, Dao JJ, Zhang W, Liu J, Ma YK, Qiao CM, Cui C, Chen SX, Shen YQ, Zhao WJ

DOI: 10.1016/j.neurot.2025.e00739
Published: 2025 Oct
Container: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2025.e00739,
  title = {Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model.},
  author = {Liu C and Zhao Y and Dao JJ and Zhang W and Liu J and Ma YK and Qiao CM and Cui C and Chen SX and Shen YQ and Zhao WJ},
  year = {2025},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  doi = {10.1016/j.neurot.2025.e00739},
  url = {https://doi.org/10.1016/j.neurot.2025.e00739}
}

RIS

TY  - JOUR
TI  - Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model.
AU  - Liu C
AU  - Zhao Y
AU  - Dao JJ
AU  - Zhang W
AU  - Liu J
AU  - Ma YK
AU  - Qiao CM
AU  - Cui C
AU  - Chen SX
AU  - Shen YQ
AU  - Zhao WJ
PY  - 2025
JO  - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
DO  - 10.1016/j.neurot.2025.e00739
UR  - https://doi.org/10.1016/j.neurot.2025.e00739
ER  -

APA

C, L., Y, Z., JJ, D., W, Z., J, L., YK, M., CM, Q., C, C., SX, C., YQ, S., & WJ, Z. (2025). Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1016/j.neurot.2025.e00739

Source records

pubmed · retrieved 2026-09-26T20:22:25.457Z